Inscripta merged with Manus in April 2025 to establish a unique end-to-end platform for scalable development, biomanufacturing, and commercialization of bioalternative products.
By combining Inscripta’s advanced whole-genome engineering technologies with Manus’ proven cell factory engineering platform, biomanufacturing expertise, and commercialization capabilities, the merged company – Manus – is uniquely positioned to deliver commercial momentum and scaled profitability in next-generation industrial biotechnology.
Company Details
- Employees
- 34
- Founded
- -
- Address
- Boston, Ma, Us
- Phone
- (720) 759-4088
- pr****@****pta.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- inscripta.com
- Keywords
- Manager jobs.
- HQ
- Boston, MA
Inscripta, Inc. Questions
Inscripta, Inc.'s helpline number is (720) 759-4088
Inscripta, Inc.'s website is inscripta.com
Inscripta, Inc.'s LinkedIn profile is https://www.linkedin.com/company/inscriptainc
Inscripta, Inc. has
34 employees.
View email and phone details for 34
employees at Inscripta, Inc..
Inscripta, Inc.'s industry is
Biotechnology Research
Inscripta, Inc.'s top competitors are
10x Genomics,
Somascan,
Think Bioscience,
Edgewise Therapeutics,
Enveda,
Watchmaker Genomics,
Manus,
Biodesix, Inc.,
Element Biosciences,
Mosaic Biosciences.
Inscripta, Inc.'s support email address is press@inscripta.com
Inscripta, Inc.'s categories are Biotechnology Research
Inscripta, Inc.'s founding year is 2015
